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ABSTRACT We describe a statistical approach to the validation and improvement of molecular dynamics simulations of
macromolecules. We emphasize the use of molecular dynamics simulations to calculate thermodynamic quantities that may be
compared to experimental measurements, and the use of a common set of energetic parameters across multiple distinct mole-
cules. We brieﬂy review relevant results from the theory of stochastic processes and discuss the monitoring of convergence to
equilibrium, the obtaining of conﬁdence intervals for summary statistics corresponding tomeasured quantities, and an approach to
validation and improvement of simulations based on out-of-sample prediction. We apply these methods to replica exchange
molecular dynamics simulations of a set of eight helical peptides under theAMBERpotential using implicit solvent.Weevaluate the
ability of these simulations to quantitatively reproduce experimental helicity measurements obtained by circular dichroism. In addi-
tion, we introduce notions of statistical predictive estimation for force-ﬁeld parameter reﬁnement. We perform a sensitivity analysis
to identify key parameters of the potential, and introduce Bayesian updating of these parameters. We demonstrate the effect of
parameter updating applied to the internal dielectric constant parameter on the out-of-sample prediction accuracy asmeasured by
cross-validation.
INTRODUCTION
Computer simulation, especially molecular dynamics simu-
lation, has become an important and widely used tool in the
study of biomolecular systems (1–3). With the growing
availability of high-speed desktop computers and cluster
computing, simulations once requiring access to specialized
supercomputers are now within the range of many individual
laboratories. Nevertheless, simulation of macromolecules
such as proteins and nucleic acids remains a computationally
expensive, complicated process with many options and pa-
rameters that may signiﬁcantly affect the results. An impor-
tant step in the development of standardized simulation
approaches for such problems is the study of predictive
power—the ability of the simulation to reproducibly generate
some externally validatable quantity such as a future experi-
mental measurement. In ﬁelds such as physics and chemistry,
aswell as inmacroscopic areas of engineering and astronomy,
simulations are regularly used in lieu of physical experiment,
due to their ability to accurately and consistently predict
physical quantities. Currently macromolecular simulations
are primarily used for exploratory and visualization purposes,
rather than quantitative prediction. However, as computa-
tional resources grow and algorithms and theory improve, we
can strive to develop truly accurate macromolecular computer
experiments.
To do so, we must meet several challenges. First, molec-
ular dynamics simulations of macromolecules typically
generate conﬁgurations on a pico- or femtosecond timescale,
due to limiting frequencies of bond vibration. Because we
cannot experimentally observe the motions of protein atoms
at such timescales, the quantities measured in experimental
settings can only ever be time-averaged quantities. With the
exception of single-molecule experiments, most experimen-
tal studies of macromolecules are also ensemble-averaged.
Thus, we must be concerned primarily with the time- and
ensemble-averaged behavior of our simulation model, which
may be validated against real experimental observations.
Because it cannot be compared against reality, more detailed
information generated by a simulation such as speciﬁc atomic
trajectories or kinetic pathways should be viewed with some
skepticism. This distinguishes molecular dynamics simula-
tions of macromolecules from common use of classical me-
chanics simulations in macroscopic engineering applications,
where larger timescales allow for trajectories themselves to
be predictively validated against observation.
Thus, to compare simulation with experiment requires the
computation of ergodic average quantities under our theo-
retical model (molecular mechanics potential). As is well
known, doing so requires adequate exploration of confor-
mational space during the simulation, a difﬁcult problem.
However, modern simulation algorithms (4,5) have made it
possible to achieve adequate sampling for small systems. We
also require methods for determining when adequate sam-
pling has been achieved. Finally, because sample path av-
erages are only approximate due to ﬁnite simulation lengths,
we must quantify the remaining uncertainty in computed
quantities to properly compare themwith experimental values.
Some standard statistical methods for addressing these issues
are described in Statistical Analysis of Simulation Output.
A grand challenge of macromolecular simulation is the sim-
ulation of protein folding (6). Adequate ensemble-averaging
for large proteins remains beyond current computational
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resources; here we study helical peptide folding, which has
been widely studied as a model system for protein folding
both experimentally (e.g., (7), and the large body of subse-
quent literature summarized in (8)) and computationally (in
(9–16)). For short helical peptides, using modern simulation
algorithms and a cluster of computer processors, we are able
to adequately address the sampling issue. We apply our ap-
proach to study eight helical peptides from the experimental
literature, and compare results obtained from simulation to
experimental data.
A common concern is whether existing force ﬁelds are
adequate to simulate protein folding. We approach this
question from a predictive perspective: all molecular me-
chanics potentials are ‘‘wrong,’’ but we can ask whether they
are ‘‘good enough’’ to accurately predict speciﬁed experi-
mental quantities of interest, just as we judge any other the-
oretical model. Due to the difﬁculties of comparing
simulations against experiment described above, it has pre-
viously been very difﬁcult to separate the question of force-
ﬁeld accuracy from that of adequate conﬁgurational sampling.
Here we systematically and quantitatively address the latter,
enabling us to focus on the former. In particular we ask the
question: given reproducible, quantitative predictions of en-
semble quantities (here, equilibrium helicities), how well do
the force ﬁeld and parameter values used predict experimental
quantities (here, circular dichroism (CD) measurements)?
In taking a predictive perspective, we emphasize the need
for a single set of energy parameters, which successfully
predict experimental quantities of multiple different molec-
ular systems. Recent work has evaluated simulation versus
experiment for helicity and thermal melting of single peptides
(11,15). However, the force ﬁelds and parameter settings
chosen for simulation studies often vary signiﬁcantly across
studies, making generalizability difﬁcult to assess: in this
article, we show that the ranges of parameter values used in
the literature provide widely different equilibrium values. In
addition to choice of parameters, often the force ﬁeld may be
modiﬁed to improve reproduction of experimental values, an
issue we address from a formal statistical perspective. A
single set of parameters (or well-deﬁned criteria for choosing)
is critical for prediction of a new molecular system by simu-
lation.
We emphasize that helicity is a coarse-grained measure of
the equilibrium ensemble and thus provides only a ﬁrst step
in evaluating the simulation accuracy; in this manner our
approach is meant to be demonstrative rather than exhaustive.
However, even by looking only at helicity, we obtain im-
portant results about reproducibility, parameter sensitivity,
and experiment predictive accuracy using a common set of
parameters for simulations of multiple distinct peptide sys-
tems.
The outline of the remainder of the article is as follows.
Replica-Exchange Molecular Dynamics describes the simu-
lation algorithm (replica-exchange) used in our studies. Sta-
tistical Analysis of Simulation Output describes the statistical
tools used to determine when the simulation has converged
and to measure the accuracy of quantities computed from the
simulation trajectories. Parameter Adaptation explores the
critical issue of sensitivity of simulation quantities to the
parameters of the simulation potential, and demonstrates the
use of Bayesian statistics to estimate improved parameter
values based on available experimental data. Results gives
the results obtained from applying our approach to evaluate
predictive accuracy for the eight peptides in Table 1.
THEORY AND METHODS
We have run extensive molecular dynamics simulations for eight helical
peptides, some naturally occurring and some designed, which have been
previously studied experimentally by CD and shown to have measurable
helicity (mean u222 ellipticity) in solution. Table 1 shows the peptides studied
along with their original experimental characterization; these peptides were
selected from a database of helical peptides (8) to obtain a range of helicities
among native peptides at physiological pH.
Replica-exchange molecular dynamics
All simulations were performed using replica-exchange molecular dynamics
(REMD) (17), an application of the parallel tempering method (18) to mo-
lecular dynamics (MD) simulation. REMD runs isothermal molecular dy-
namics simulations in parallel at a ladder of temperatures and attempts to
swap chains between temperatures intermittently. Each replica was run under
the AMBER94 force ﬁeld using the AMBER 7 suite of programs (19) with a
generalized Born model of implicit solvent (20,21) and a time step of 2 fs.
SHAKE (22) was used (tolerance 53 105 A˚) to constrain hydrogen atoms,
and a weakly-coupled heat bath with coupling constant of
l ¼ 11 Dt
2tT
TN
T
 1
 
is used to maintain constant temperature (23), where TN is the ﬁxed reference
temperature and tT ¼ 1.0 controls the strength of the coupling. The speciﬁc
force ﬁeld, solvent, and heat bath parameters used are given in Table 2, and
are an attempt to replicate as closely as possible a protocol which has
previously been successful in simulating helical peptide folding (11,24). A
key question in the wider use of simulation techniques is whether such
parameter sets that are successful in one instance are generalizable to other
systems; in Results we explore this issue by evaluating the use of these
parameters to predict experimentally measured helicities for the eight distinct
peptides given in Table 1. A more detailed exploration of the effect of
varying these parameter choices is described in Parameter Adaptation.
TABLE 1 Helical peptides studied by simulation in this article,
along with original experimental characterization and conditions
ID N- Peptide sequence C-
Experimental
helicity
Temp
(K) pH Reference
DG — DGAEAAKAAAGR Nhe 0.196 273 7 (46)
SA Ace SAEDAMRTAGGA — 0.168 273 7 (47)
RD — RDGWKRLIDIL — 0.050 277 7 (48)
ES — ESLLERITRKL — 0.217 277 7 (48)
LK Ace LKEDIDAFLAGGA Nhe 0.150 298 7 (49)
PS Ace PSVRKYAREKGV Nhe 0.097 298 7 (49)
RE Ace REKGVDIRLVQG Nhe 0.134 298 7 (49)
AE Ace AETAGAKFLRAHA Nhe 0.126 276 7 (50)
Peptides are either unblocked or have an N-terminal acetyl group (Ace)
and/or a C-terminal amide group (Nhe). ID provides the peptide identiﬁer
used in other ﬁgures in this article.
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Our REMD protocol utilizes 30 distinct MD simulations run in parallel at
temperatures ranging from the target temperature T0 (273 Kelvin, 276 K, 277
K, or 298 K) to T29 ¼ 624 K for each peptide simulation. Temperatures are
spaced exponentially with Ti ¼ ºT0 exp [ki]c, where k ¼ ln(624/T0)/29 and
i ¼ 0, . . ., 29. During the REMD simulation, each replica is run at the as-
signed temperature for cycles of 1000 MD steps (2 ps), after which the
translational and rotational motion of the center of mass is removed and 300
temperature-swapping moves attempted, as per a previous protocol (24).
(Postsimulation analysis of swap acceptance rates indicated that approxi-
mately half as many replicas would have sufﬁced; this can be explained by
fact that the protocol adopted from (24) was designed for use with both
implicit and explicit solvent, the latter necessitating more replicas.)
Let xT ¼ (p, q)T denote the coordinates (positions and momenta) of the
replicate at temperature T. At each temperature-swap, two replicas xA and xB
are chosen at random and a swap of their respective temperatures TA and TB
is proposed, with acceptance probability given by the Metropolis criteria,
Paccept ¼ min 1;pðxB; TAÞpðxA; TBÞ
pðxA; TAÞpðxB; TBÞ
 
;
where p(x, T) } exp[–E(x)/kBT] is the Boltzmann distribution over conﬁg-
urations at temperature T, and E is the total energy EðxÞ ¼ UðxÞ1
DGsolv1 12+ikpik2=mi with U the potential function given by Eq. 4 and
DGsolv the implicit solvent free energy term given by Eq. 5. When a swap is
accepted, the two replicas exchange temperatures; otherwise, they remain at
their respective temperatures. Associated velocities are rescaled to reﬂect the
temperature swap before the next cycle of MD steps. This process of 1000
MD steps followed by 300 attempted temperature swaps is repeated until the
convergence criteria described in Statistical Analysis of Simulation Output is
reached.
The above REMD protocol is used to conform as closely as possible to
existing uses of REMD in protein simulation in the literature. TheMetropolis
criteria is used to guarantee invariance of (and therefore convergence to) the
Boltzmann ensemble; however, recent theoretical analysis shows that cor-
rections are needed to guarantee the proper invariant measure (25).
Statistical analysis of simulation output
As described above, molecular dynamics simulations of molecules differ
somewhat from the use of classical mechanics simulations in macroscopic
engineering applications, since detailed comparison of dynamical trajectories
to experimental data is typically impossible. In fact, such trajectories are
highly sensitive to starting conditions (26), parameterizations of the energy
model, and other simulation details. Instead, it is the long-run, time-
averaged behavior of the simulation that we can expect to produce observ-
able macroscopic (thermodynamic) physical quantities, if the simulation
model is adequate. To evaluate simulations against experimental data then,
we must be able to accurately compute the long-run, time-averaged behavior
implied by our theoretical model, speciﬁed by the molecular force ﬁeld or
potential. To do so, we rely on two important results. First, an ergodic the-
orem saying that if the dynamics of our simulation are ergodic (able to reach
any region of the conﬁguration space from any other region), then the time-
averaged behavior of the simulation will converge to the conﬁguration space
integral representing the ensemble-averaged behavior for any (integrable)
quantity of interest. Writing the quantity of interest as a function h(x) of
conﬁgurations x in conﬁguration space X, we have
lim
t/N
1
t
Z t
0
hðxðsÞÞ ds ¼ Z1
Z
hðxÞe 1kBTEðxÞdx¼def ÆhæT (1)
for the canonical (constant N,V,T) ensemble, where Æhæ denotes the expec-
tation or ensemble average of h(x) under the stationary Boltzmann distribu-
tion. Here h(x) is any quantity we wish to compute from a given
conﬁguration, and may be used to compute means (e.g., internal energy or
helicity), variance-covariance matrices (for essential dynamics), indicator
functions (for free energies), and so on. A major advantage of simulation-
based methods is the ability to calculate a variety of such quantities from a
single simulation. The right-hand integral yields the ensemble-averaged
quantity under the theoretical model (force ﬁeld); it is this quantity that can be
compared with real-world experiments, which are themselves averaged over
both time and molecules in solution.
Because we cannot run simulations inﬁnitely long, we can only ever
compute an approximation to the left-hand side of Eq. 1. Therefore, to use
this result in practice, we need to know two things: how long must the
simulation be run such that this approximation is ‘‘pretty good’’ (the con-
vergence in Eq. 1 is approximately achieved), and how good is ‘‘pretty
good’’ (error bounds on the computed quantities). Not only must the simu-
lations have reached equilibrium, but they must also have run in equilibrium
long enough to produce accurate approximations of the time/ensemble-
averaged quantities of interest. From this perspective, MD simulation is
simply a tool for computing the integral (Eq. 1), and often alternative nu-
merical integration methods such as Monte Carlo sampling or replica-ex-
change dynamics may be more efﬁcient than standard MD at this task.
However, these methods often disrupt the kinetics of the process; interest-
ingly, recently developed simulation methods, which do not guarantee
proper ensemble sampling, may be useful in taking ensemble samples gen-
erated by methods such as MC or REMD and reconstructing the kinetics
(27).
Another important result is statistical and provides guidance on these
questions. It says that, for well-behaved functions h(x), the time-average of h
computed from a simulation ofN steps converges to the true value Æhæ asN/
N. (Here ‘‘well-behaved’’ means h(x) has ﬁnite variance under Boltzmann
distribution p(x), and the simulation dynamics are geometrically ergodic
(28), a stronger assumption that can be difﬁcult to verify in practice (B.
Cooke and S. C. Schmidler, unpublished).) Moreover, this sample path
average obeys a central limit theorem, converging in distribution to a normal
random variable centered at the true value Æhæ,
hˆ ¼ 1
N
+
t
hðxðtÞÞ/d NðÆhæ;s2hˆÞ
where s
2
hˆ ¼ s2h 11 2
Z
t
rðtÞdt
 
; (2)
where s2h ¼ Æh2æ Æhæ2 is the variance of h(x) under the Boltzmann distri-
bution p(x), and rðtÞ ¼ Æðhðxt0 Þ  hðxt01tÞÞ2æ=s2h is the autocorrelation
function for ﬂuctuations in h of conﬁgurations at time separation t when
the process is in equilibrium. Note that the Metropolis step in REMD creates
a stochastic process (25), so we state results in those terms; central limit
theorems for deterministic ergodic dynamical systems exist but are some-
what more delicate. Determinism ofMD for molecules in solution is artiﬁcial
and often replaced with stochastic (Langevin or Brownian) dynamics. In the
stochastic case, however, ergodicity of the system is not an assumption, but
can be shown directly.
This theoretical result has important implications. It provides the distri-
bution of errors obtained when we use the time average from a ﬁnite length
simulation to approximate the theoretical ensemble average. This allows us
to quantify uncertainty and produce error bars based on (100-a)% conﬁdence
intervals, which is critical for comparing the simulation output with exper-
TABLE 2 Force-ﬁeld and simulation parameters used in the
helical peptide replica-exchange simulations, and as default
values for the parameter sensitivity analysis
Simulation
parameter eext ein
Salt
concentration
Nonbonded
cutoff See Snb edielc
Default value 78.5 4.0 0.0 M 8.0 A˚ 1.2 1.0 1.0
Parameters values are those used previously for simulating a helical peptide
(24).
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imental data. This in turn allows us to determine simulation time needed to
approximate quantities to a predetermined level of accuracy. Failure to run a
simulation long enough to adequately estimate quantities of interest is a
common pitfall of molecular dynamics simulation (29).
In addition, knowledge that the errors are approximately normally dis-
tributed allows us to treat the simulation model as a (rather complicated)
statistical model, and perform likelihood-based statistical inference on the
simulation parameters, as described in Parameter Adaptation.
Interval predictions
Acritical aspect of comparing simulation outputwith experiment is to account
for the inherent variability of both the simulation output and the experimental
measurement. As described above, variability in the simulation output can be
characterized by a central limit theorem: the quantity hˆ approaches Æhæ in the
limit of largeN, with error Æhæ hˆ beingnormally distributedwith variances2
hˆ
given by Eq. 2. This result allows us to construct normal-based conﬁdence
intervals for h of the form Æhæ6 2sˆhˆ: The variance of hˆ therefore determines
how longwe need to run a given simulation to obtain a predetermined level of
accuracy. Since sh depends on the function h of interest, some quantities can
converge signiﬁcantly faster than others, a fact observed empirically (30);
however, apparent convergence of some quantities while others have not
converged can also be misleading. Theoretical guarantees on how long a
simulation must be run are extremely difﬁcult to come by, although recent
progress has been made in this area for parallel tempering algorithms (31).
To determine this interval we require an estimate sˆhˆ for shˆ: Direct esti-
mates of the summed autocorrelation (Eq. 2) are inconsistent, but several
other estimation methods exist (32). A common and relatively straightfor-
ward technique, which we use here, is the batch estimate, obtained by di-
viding the simulation of length N into a ¼ N/M regions or batches of sizeM.
Each batch is used to independently estimate Æhæ,
hˆi ¼ 1
M
+
ði11ÞM
k¼iM
hðxkÞ and hˆ ¼ 1
a
+
i
hˆi
and M is chosen large enough to ensure the autocorrelation rhˆi ;hˆi11  0: The
batch estimates are then approximately independent sampleswhose empirical
variance
sˆ
2
hˆ ¼
1
a 1+i
ðhi  hˆÞ2
yields a simple estimate of the variance s2
hˆ
: The quantile plot in Results (Fig.
4 a) indicates approximate normality is a reasonable assumption for our
converged simulations.
Monitoring convergence
The energy surface of proteins and polypeptides is characterized by large
energy barriers and multiple local minima, making adequate exploration of
conﬁguration space a major challenge of protein simulation. While theoret-
ical guarantees are very difﬁcult to obtain for complex simulations, and
observing the output of a simulation can never guarantee convergence,
convergence diagnostics can be constructed to identify lack of convergence
from simulation output. Our preferred approach is the use of multiple parallel
simulations starting from diverse initial conditions to monitor the conver-
gence by comparison of sample path quantities across distinct simulations.
We use the multiple-chain approach (33) to assess convergence of our sim-
ulations by running multiple independent REMD simulations for each pep-
tide in parallel starting from a diverse set of initial conﬁgurations, with each
individual REMD simulation run according to the protocol of Theory and
Methods. Let M denote the number of simulations and xðiÞj for j ¼ 1, . . ., M
the conﬁguration of the jth simulation at time step i. Convergence of an
observable quantity h(x) is by calculating
BN ¼ 1
M
+
M
j¼1
ðhj  hÞ2 and WN ¼ 1
NM
+
M
j¼1
+
N
i¼1
ðhðxðiÞj Þ  hjÞ2
with hj ¼ 1N+
N
i¼1 hðxðiÞj Þ; and h ¼ 1M+
M
j¼1 hj: The value BN represents the
between-chain variability and WN represents the within-chain variability.
When multiple starting conﬁgurations are chosen to be widely dispersed
throughout conﬁguration space, early in the simulation the chains will be
sampling distinct regions of phase space and the between-chain variance will
be signiﬁcantly higher than the within-chain. As the simulations converge to
sampling from the same equilibrium Boltzmann distribution, these two
quantities will converge. Comparison is based on techniques from the
analysis of variance to determine whether signiﬁcant differences remain. and
convergence is monitored using the Gelman-Rubin shrink factor (37)
ﬃﬃﬃﬃﬃ
RN
p ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
N  1
N
1
M1 1
M
BN
WN
vN
vN  2
r
;
where vN ¼ 2ðsˆ2N1BNM Þ2=WN: The quantity
ﬃﬃﬃﬃﬃﬃ
RN
p
estimates the reduction in
variance of the estimator hˆ if the simulationwere to be run inﬁnitely long, and
converges to one as all of the parallel simulations converge to equilibrium.
Once the chains have equilibrated, samples from all M ¼ 4 independent
simulations can be combined to obtain a pooled estimateof Æhæ, with individual
chain estimates combined inversely proportional their respective variances:
hˆ ¼
+
j
hˆ
j
sˆ
2
hˆj
+
j
sˆ
2
hˆj
and sˆ
2
hˆ ¼ +
j
sˆ
2
hˆj
 !1
: (3)
Thus the effective trajectory length of the combined estimate isMN where N
is the average production phase length; the only price paid for using multiple
simulations compared to a single simulation is the replication of the
equilibration phase. In our opinion, the advantage of being able to run in
parallel and to obtain convergence diagnostics by inter-run comparisons far
outweighs this cost in most situations. Note that combining the results of
multiple simulations that have not been determined to have individually
converged to the same stationary distribution, as is sometimes done in MD
simulation, has no theoretical justiﬁcation and can be badly misleading.
Numerous other convergence diagnostics have been developed in the
statistics and operations research literature (34), including further develop-
ments of the approach used here (35,36). Note that no diagnostic based on
simulation output can ever guarantee convergence, all such diagnostics can
be fooled (34). However, theoretical bounds on simulation time are very
difﬁcult to obtain; although relevant work in this direction is ongoing (31).
Parameter adaptation
The energetics used in molecular dynamics simulations involve a large
number of parameters that must be speciﬁed in advance. These include the
parameters of the AMBER potential (19), given by the covalently-bonded
and nonbonded terms,
UðxÞ ¼ +
bonds
Krðr  reqÞ21 +
angles
Kuðu ueqÞ21 +
dihedrals
Vn
2
½11 cosðnf gÞ
1 +
i, j
i;j;V14
Aij
r
12
ij
 Bij
r
6
ij
1
qiqj
erij
" #
1 +
i, j
i;j2V14
1
Snb
Aij
r
12
ij
 Bij
r
6
ij
 !
1
1
See
qiqj
erij
" #
; (4)
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where V1–4 is the set of atom pairs (i, j) which are separated by three bonds.
For example, the parameter See weights the electrostatic interactions inV1–4,
Snb weights the corresponding van der Waals interactions, and the dielectric
constant e affects all longer-range electrostatic terms.
In addition, the implicit-solvent model given by the generalized Born
approximation (20,21) has associated parameters,
DGsolv ¼ +
a2A
baaaðxÞ1DGpol; (5)
whereA is the set of atom types,aa is the total solvent-accessible surface area
of atoms of type a in conﬁguration x, ba are solvation parameters, and the
electrostatic polarization component of the free energyof solvation is givenby
DGpol ¼ 1
2
+
i;j
1
emol
 1
ewater
 
qiqj
fGBðrijÞ; (6)
which involves parameters such as the intramolecular dielectric constant emol
and the solvent dielectric ewater. (In AMBER, these parameters are speciﬁed
as ein, eext, and edielc, with ewater¼ eextedielc, emol¼ einedielc, and e¼ einedielc.)
Although in principle, these parameters represent physical quantities whose
values can be known; in practice, they are approximations with values
determined individually in empirical or theoretical studies.
The simulations of Results utilize a default set of parameters given in
Table 2, chosen to comply with standard practice as described in Theory and
Methods. Nevertheless, there is signiﬁcant variation in the literature in values
chosen for some of these parameters. Since the ensemble simulated is deﬁned
by these parameters, the simulation averages obtained and their comparison
with experimental values will be a function of these parameter choices. It is
therefore important to understand the how differences in these parameter
values may be propagated into the resulting thermodynamic quantities esti-
mated, and to determine the impact on the conclusions obtained. Sensitivity
analysis of these parameters is described in Sensitivity Analysis.
Bayesian estimation of force-ﬁeld parameters
Given the sensitivity of simulation results to certain force-ﬁeld parameters as
demonstrated in Sensitivity Analysis, we identify a standard set of values that
could be used by various researchers to ensure consistency and comparability
of simulations across different studies. A natural approach to determine such
values is to optimize the parameter values with reference to experimental
data. However, it is important to do so in such a way that the resulting pa-
rameter values are generalizable to other systems. A criticism commonly
leveled at simulation research is that with the large number of parameters
involved in specifying a potential energy function, a solvation model, and a
simulation algorithm, the simulation may be adjusted to produce almost any
behavior the investigator desires.
Such concerns can be addressed by standardized use of a common set of
parameters, but the adaptation of these parameters to better match experi-
mental observations remains important. The danger is that optimizing pa-
rameters on a speciﬁc set of data may provide good results, but generalize
poorly to the study of other systems, a phenomenon known as overﬁtting.
One solution to overﬁtting is the use of large datasets relative to the number
of parameters, where the simultaneous adaptation to multiple experimental
measurements ensures that no particular measurements are well described at
the expense of others. We do have large quantities of experimental helicity
data available (8), but we are currently limited by the fact that each data point
requires parallel simulations at nanosecond or greater timescales for inclu-
sion. However, overﬁtting is also avoided by a variety of parameter esti-
mation and predictive validation techniques developed in statistics, such as
Bayesian analysis and regularization. These techniques, which penalize large
parameter changes when insufﬁcient data is available to justify them, regu-
larly allow the adaptation of complex, many-parameter models to relatively
small data sets while avoiding overﬁtting and producing parameters that
generalize well. In this article, we adopt a Bayesian approach, using prior
information to adapt the parameters by Bayesian inference. Because com-
putational considerations limit us to the use of the eight peptides in Table 1,
we perform only a small example of this approach, adapting only one pa-
rameter at a time. Computational methodology for adaptation of many pa-
rameters simultaneously will be described elsewhere.
To evaluate generalizability of the parameters resulting from this adap-
tation approach, we apply the statistical method of cross-validation. This
allows us to estimate out-of-sample prediction accuracy, i.e., how accurately
we can expect these parameters to perform when simulating a new peptide to
predict its experimental helicity.
We ﬁrst specify a simple statistical error model for the experimental data,
which says that the measured helicities may be described as a combination of
the theoretical equilibrium helicity under our force ﬁeld, plus some experi-
mental noise:
h
exp
R ¼ ÆhRæu1 e e;Nð0;s2Þ: (7)
Here hexpR denotes the experimentally measured helicity of peptide R, and we
now denote explicitly the dependence of Æhæ on the peptide sequence R as
well as the force-ﬁeld parameters u. If ÆhRæu was a linear function of the
parameters u, then Eq. 7 would simply be a linear regression model. Instead,
the ensemble helicity ÆhRæu is a complicated function given by the conﬁg-
uration integral under the Boltzmann distribution with potential function (Eq.
4) parameterized by u. Similar statistical principles apply, however, allowing
us to estimate the parameters u from data. This has a slightly unusual aspect
arising from the difﬁculty in calculating ÆhRæu, which can only be done
approximately by the simulation average from a ﬁnite length simulation as
described in Statistical Analysis of Simulation Output. The assumption of
normally distributed noise can be justiﬁed by the previously described central
limit theorem for ÆhˆRæ as well as standard usage for experimental noise; the
quantile plot in Results (Fig. 4 b) shows that this assumption is quite
reasonable.
The Bayesian approach next speciﬁes a prior distribution for the param-
eter P(u), which captures any background or biophysical knowledge we may
have about the parameter, to supplement the information contained in the
experimental data. We then base our inference about the parameter on the
posterior distribution,
PðujDataÞ ¼ PðDatajuÞPðuÞR
PðDataju9ÞPðu9Þdu9}PðuÞ
Yp
i¼1
f
hˆ
u
i hexpi
sexp1shˆui
 !
;
(8)
where p is the number of peptides,f is standard normal density function, and
hˆui is the simulated helicity from Eq. 3 for peptide i run at parameter value u.
Note that s2exp reﬂects the variance in h
exp
i arising from experimental noise,
and s
hˆ
u
i
is the remaining simulation uncertainty in hˆui given in Eq. 3. We do
use the estimated value sexp ¼ 0.07, from Schmidler et al. (8), for con-
venience; more formally sexp could be estimated or integrated out to obtain
the marginal posterior distribution (37).
RESULTS
Predicting helicity of multiple distinct peptides
by simulation with a single parameter set
REMD simulations were performed for the eight peptides
given in Table 1. For each peptide, four REMD simulations
were run in parallel, with each REMD simulation utilizing 30
temperatures according to the protocol of Theory and
Methods. Initial conﬁgurations for the four REMD runs were
generated as follows for each peptide: one ideal helix, one
extended conformation, and two random conﬁgurations, one
generated by uniformly sampling (f, c) angles within the
helical range and one generated by uniformly sampling (f,c)
outside of the helical range. Fig. 1 a shows the starting
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conﬁgurations for a particular peptide at T0. Initial velocities
were generated randomly and independently for each con-
ﬁguration. Quantities monitored for convergence included
backbone f- and c-angles of each amino acid, helicity of the
peptide, and total energy. Convergence to equilibrium was
declared when the Gelman-Rubin shrink factor for these
quantities reached 1.1, and the sample paths up to this time
(equilibration phase) discarded. Sample paths from this time
on (production phase) were included in computing time-av-
eraged quantities hˆ: Fig. 2 shows plots of the Gelman-Rubin
shrink factor for simulations of the eight peptides; for com-
parison, a standard MD simulation (without replica-ex-
change) of one of the peptides is shown.
Helicity of a peptide conﬁguration was deﬁned as the
fraction of amino-acid (f, c) pairs lying in a predeﬁned
helical range with the potential to form hydrogen bonds,
hðxÞ ¼ 1ðl 2Þ+
l1
i¼2
Yi11
j¼i1
1ðflo#fðxjÞ#fhiÞ1ðclo#cðxjÞ#chiÞ; (9)
for conﬁguration x of a peptide of length l, where 1() is an
indicator function. We use a standard range for deﬁning
helical angles: fflo, fhig ¼ f87, 27g and fclo, chig ¼
f77, 17g (see Helical Backbone Angles for the effect of
changing these boundaries on the resulting helicities).
The total simulation time required to reach convergence for
each peptide is shown in Table 3. After equilibration, each
simulationwas continued until the estimated variance sˆ2
hˆ
of the
combined estimate of equilibrium helicity (Eq. 3) decreased to
,0.001. The total simulation times required in the production
phase to meet this criteria are also shown in Table 3.
Fig. 3 shows the simulated equilibrium helicities versus the
published experimental helicities in Table 1. All experimental
FIGURE 1 Three conﬁguration snapshots
from the four parallel REMD simulations of
peptide SAEDAMRTAGGA. Shown are (a) the
four starting conﬁgurations, (b) four conﬁgura-
tions observed at time of convergence to equi-
librium, and (c) four conﬁgurations from the
production phase of the simulation.
FIGURE 2 Convergence of REMD sim-
ulations of the eight peptides from Table 1,
as measured by the Gelman-Rubin shrink
factor (37) for helical content. Black lines
represent the estimated shrink factor with
dashed lines giving the boundary of the 95%
conﬁdence interval. Each plot represents
convergence between four parallel simula-
tions started from diverse initial conﬁgura-
tions using parameters given in Table 2.
Shown for comparison (lower right) is a
convergence plot for four standard MD
simulations of peptide AE simulated with-
out replica-exchange.
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helicities are derived from mean-residue u222 ellipticity
measured by circular dichroism. Simulated helicities are
shownwith 95% conﬁdence intervals obtained as described in
Statistical Analysis of Simulation Output. For each peptide,
we show the helicity interval obtained from each of the four
independent REMD runs as well as the combined estimate hˆ
(Eq. 3). Simulated helicities are correlated with the experi-
mental helicities but are not within perfect agreement even
within the sampling error of the simulations. Recent estimates
place the standard deviation of experimental noise to be
;0.05, so the simulations may agree within the tolerance of
combined noise due to ﬁnite simulation sampling and experi-
mental error. Fig. 4 shows quantile plots that validate the nor-
mality assumptions given in Theory and Methods.
Sensitivity analysis
To address the questions of sensitivity of simulation results to
choice of simulation parameters described in Parameter
Adaptation, we performed a one-way sensitivity analysis of
seven of the force-ﬁeld parameters described there:
The external and internal dielectrics eext and ein.
The salt concentration constant used with implicit sol-
vent, Salt.
The weight terms See and Snb, for atom pairs in V1–4.
The dielectric constant edielc.
A simulation parameter for the nonbonded cutoff dis-
tance, Cutoff.
Ranges for these parameters were chosen based on the
variation in use in published simulation studies and recom-
mended values in force-ﬁeld documentation.
Sensitivity analysis was performed via short REMD sim-
ulations of two peptides (DGAEAAKAAAGR and SAE-
DAMRTAGGA) starting from equilibrium states obtained
from the longer simulations of Results. Parameters given in
Table 2 were used as reference values, and each parameter
was varied individually while holding the others constant,
performing short REMD simulations of 200 ps for each
peptide at 273 K. Four copies of each were run from different
equilibrium starting conﬁgurations to monitor convergence
as described in Monitoring Convergence. The resulting
sensitivity of helicity to perturbations of these seven pa-
rameters is shown in Table 4. Of the parameters examined,
the internal dielectric constant ein has the most dramatic ef-
fect on the helicity obtained from simulation.
The results in Table 4 suggest that the variability among
choices for both ein and Snb observed in the literature may
signiﬁcantly impact the thermodynamic quantities measured
from these simulations. To evaluate the ability of this po-
tential and solvent model to reproduce experimental hel-
icities, we must obtain an appropriate consistent value for this
and other parameters.
Effect of ein and Snb parameters
Variation of the two force-ﬁeld parameters ein and Snb
showed a signiﬁcant effect impact on the helicity of the two
peptides studied in the one-way sensitivity analysis. We fo-
cus on determining an appropriate value for ein in Bayesian
Estimation of Internal Dielectric ein, but ﬁrst we explore the
manner in which these parameters affect helicity. The value
ein affects both the solute-solvent electrostatic polarization
term in Eq. 6 and nonbonded electrostatic interactions in
Eq. 4. The DGpol term represents a difference in electrostatic
interaction energy resulting from solvent screening of
charges. As ein increases toward eext this difference shrinks,
effectively increasing internal charge screening by making
the interior of the molecule more polar. The electrostatic
interactions in Eq. 4 also decrease as ein increases, reducing
the favorability of hydrogen bonds formed in helix forma-
tion. Thus we expect that increasing ein will produce lower
simulation helicity levels, as observed in Table 4. (Sensitivity
to much larger changes in the structure of the solvation model
has been previously reported (24,38), but our results show
that, even for a given solvation model, the choice of pa-
rameter values may have a large impact.)
TABLE 3 Time length of equilibration and production phases
for REMD simulations of each peptide
Peptide DG SA RD ES LK PS RE AE
Equilibration phase (ns) 0.8 0.6 0.8 0.8 1.0 1.0 1.0 1.4
Production phase (ns) 1.0 0.8 1.4 1.6 2.4 2.4 1.6 2.9
Peptide identiﬁers are given in Table 1. Equilibration and production times
were determined according to the statistical convergence criteria described in
Statistical Analysis of Simulation Output. Due to the use of replica-exchange,
equilibration is signiﬁcantly faster than physical timescales (see Fig. 2).
FIGURE 3 Peptide helicity as estimated from simulation versus experi-
mentally measured helicity for the eight peptides in Table 1. The diagonal
line y ¼ x is shown as a reference. Simulation results are shown as 95%
conﬁdence intervals using standard errors estimates described in text, and
are shown both for individual REMD runs and for the pooled estimates.
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In contrast, Table 4 shows that as Snb increases, peptide
helicity decreases. The quantity Snb scales the nonbonded van
der Waals interactions in the potential energy U (Eq. 4). To
interpret the effect of this parameter on helicity, we examined
its effect on each of the 1-4 interactions along the peptide
backbone, as well as the relation of these 1-4 distances to
amino-acid helicity. The effect of the Snb parameter on most
1-4 interactions had little effect on helicity, with the notable
exceptions of nitrogen-to-nitrogen (N-N) and hydrogen-to-
carbon (H-C) distances, as pictured in Fig. 5. Equilibrium
values of both of these distances (N-N and H-C) decrease as
Snb increases, and in turn, lowers the helicity of the associated
amino acid as shown in Fig. 6 in both peptides for which this
sensitivity analysis was performed. Changes in other 1-4
atom pair distances induced by Snb increase had little effect
on helicity; Ca-Ca is shown as an example.
Bayesian estimation of internal dielectric ein
To demonstrate the parameter adaptation approach of
Bayesian Estimation of Force-Field Parameters, we applied it
to estimate the parameter ein shown in Table 4 to have the
greatest impact on equilibrium helicity. (Computational
considerations preclude simultaneous adaptation of many
parameters using this approach, and as such, this example is
intended to be illustrative. Computational methods for
adapting many parameters simultaneously will be reported
elsewhere.) To estimate an optimal value for internal di-
electric we discretized this parameter into a set of plausible
values ein 2 f1, 2, 3, 4, 5g spanning the range of values that
have been used previously in the literature (24,39). A non-
FIGURE 4 Quantile plots of standardized residuals (left)
ðhˆij  hˆiÞ=shˆij for the 8 3 4 ¼ 32 individual REMD
simulations, and (right) ðhˆi  hexpi Þ=shˆi for the eight com-
bined simulation peptide helicities versus experiment. The
lack of signiﬁcant deviation from the diagonal suggests the
assumption of normally distributed noise is reasonable in
each case.
TABLE 4 One-way sensitivity analysis of helicity as a function
of simulation parameters
DGAEAAKAAAGR SAEDAMRTAGGA
Parameter Value Mean Variance Mean Variance
eext 100 0.188 0.0006 0.170 0.0183
80 0.189 0.0024 0.209 0.0060
78.5 0.170 0.0031 0.174 0.0183
50 0.172 0.0006 0.232 0.0050
ein 20 0.063 0.0002 0.091 0.0035
10 0.124 0.0003 0.138 0.0087
4 0.168 0.0021 0.177 0.0191
3 0.260 0.0003 0.226 0.0110
1 0.388 0.0037 0.227 0.0112
Salt 5.0 0.197 0.0015 0.219 0.0065
2.0 0.161 0.0005 0.146 0.0188
1.0 0.173 0.0002 0.186 0.0204
See 5.0 0.238 0.0004 0.262 0.0197
2.0 0.215 0.0010 0.235 0.0094
1.5 0.179 0.0002 0.197 0.0184
1.2 0.188 0.0016 0.176 0.0188
1.0 0.161 0.0010 0.192 0.0155
Snb 5.0 0.052 0.0001 0.039 0.0003
2.0 0.109 0.0016 0.104 0.0070
1.5 0.171 0.0009 0.093 0.0043
1.2 0.176 0.0018 0.158 0.0122
1.0 0.202 0.0006 0.175 0.0188
Cutoff 99.0 0.167 0.0007 0.167 0.0254
20.0 0.183 0.0008 0.173 0.0200
15.0 0.177 0.0002 0.199 0.0230
12.0 0.181 0.0004 0.228 0.0315
10.0 0.171 0.0009 0.167 0.0160
8.0 0.161 0.0002 0.209 0.0130
5.0 0.111 0.0002 0.112 0.0052
edielc 100.0 0.059 0.0002 0.060 0.0015
80.0 0.052 0.0009 0.089 0.0046
78.5 0.065 0.0010 0.125 0.0039
50.0 0.093 0.0011 0.105 0.0072
20.0 0.091 0.0003 0.067 0.0039
5.0 0.074 0.0011 0.115 0.0071
3.0 0.083 0.0011 0.119 0.0111
Shown are mean helicity and variance obtained for two peptides DGAEAA-
KAAAGR and SAEDAMRTAGGA at a range of values for each parameter
studied.
FIGURE 5 The N-N (dashed) and H-C (dotted) 1-4 interactions along the
peptide backbone, which are most affected by changes in the Snb scaling
constant in the AMBER potential. The effect of equilibrium distances for
these atom pairs has a signiﬁcant effect on the (f,c) angles of their
respective amino acids, and hence on peptide helicity.
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informative uniform prior distribution was assigned for ein by
giving each possible value of ein equal prior probability. To
obtain the posterior distribution (Eq. 8) for ein, REMD sim-
ulations as described in Replica Exchange Molecular Dy-
namics were then run for each peptide at each discrete value
of the dielectric constant with all other parameters ﬁxed at
their default values given in Table 2. The resulting posterior
distribution over the discrete values of ein is shown in Fig.
7 a. Given this shape, we decided to reﬁne the discretization
of ein by adding another value at ein ¼ 4.1 to obtain a more
detailed look at the posterior in the high probability region.
(Each such point requires eight peptides 3 4 REMD runs 3
30 MD simulations run to convergence to obtain equilibrium
helicities, hence the coarseness of the original discretization.)
The new posterior is shown in Fig. 7 b.
Fig. 8 shows estimated helicities obtained by simulation
versus experimental values for all eight peptides for the six
different values of ein. It can then be seen that the highest
posterior probability value of 4.1 is the one that gives the
closest approximation to the set of experimental values. Fig.
9 plots the simulated helicity versus the experimental helicity
individually for the eight peptides plotted at the different
values of ein. Fig. 7 b shows that resulting posterior distri-
bution is clearly peaked at 4.1. (Note that further reﬁnement
of the discretization may well lead to an improvement be-
tween 4.0 and 4.1 or 4.1 and 5.) As more experimental data
FIGURE 6 Effects of the nonbonded scaling parameter Snb on the equilibrium distances (in A˚) of successive backbone nitrogen atoms (N-N), hydrogen-
carbon atom pairs (H-C), and a-carbons (Ca-Ca). Line represents the ensemble-mean helicity for the i
th amino acid as a function of the Ni-Ni11 distance (plots a
and b), Hi-Ci distance (c and d), or Ca-Ca distance (e and f) for the two peptides DGAEAAKAAAGR (a, c, and e) and SAEDAMRTAGGA (b, d, and f).
Individually labeled points give the average N-N or H-C distance for simulations with Snb ¼ f0.5, 1, 1.2, 1.5, 2, 3, 5g. Helicity changes in response to varying
Snb can be explained by sensitivity to N-N and H-C distances; other 1-4 atom pairs have little effect on helicity as demonstrated here for Ca-Ca.
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and associated simulations are included, this posterior dis-
tribution can be updated to reﬂect the information in the
larger data set, further reﬁning the optimal value.
Helical backbone angles
As another example, we consider the boundaries of the helical
(f, c) region that deﬁne a helical backbone conformation in
Eq. 9. Although a general region may be deﬁned based on
Ramachandran plots to be f 2 ffmin, fmaxg ¼ f87, 27g
and c 2 fcmin, cmaxg ¼ f77, 17g, the exact region mea-
sured by CD at ellipticity u225 is somewhat ambiguous. We
may view the boundaries of this region to be parameters of the
statistical mechanical model and estimate them by Bayesian
inference as above. In this case, evaluation of the posterior at a
range of fHmin; f
H
min;c
H
max; and c
H
min may be done more easily
than for ein, since these are parameters of the statistical me-
chanical model for helicity but not of the force ﬁeld that de-
termines the simulation ensemble; thus, we need simply
reanalyze the trajectories rather than resimulate for each
value.
For simplicity, again we discretize and construct a four-
dimensional grid for possible values of (fHmax;f
H
min;c
H
max;
and cHminÞ: The marginal posterior distributions obtained
for (fHmin;f
H
max) under a uniform prior are shown in Fig. 10 a
and for (cHmin;c
H
max) in Fig. 10 b. Peaks representing high
probability values of (fmin, fmax) are seen at (80,50) and
(90, 40), with a ridge for fmin between 100 and 70.
The joint distribution for (cmin, cmax) exhibits a sharp peak at
(60, 40) and a minor peak at (50, 30). The ranges of
dihedral angles with the largest peaks for both f and c
contain the values for an ideal helix (f, c)¼ (57,47), but
the joint mode of (fmin, fmax, cmin, cmax) ¼ (90, 40,
60, 40) yields a narrower range than that generally ac-
cepted for helical angles (57 6 30, 47 6 30). Ridges are
centered near ideal values of57 forf and47 for c, further
increasing the probability in these regions. The ridge sug-
gests that the precise value of fmax is poorly identiﬁed, likely
due to peptide backbone geometry where, for f-values
,100 and c-values.40, backbone steric clashes prevent
conﬁgurations being sampled at all.
Cross-validation
To run further simulations, we must choose a particular value
for the internal dielectric parameter; a natural choice is the
mode of the posterior distribution at ein ¼ 4.1. This value
gives the best agreement between the experimental helicities
and the simulated helicities for our observed peptides.
However, we wish to know how sensitive this result is to
the particular set of peptides chosen, and thus how well we
can expect this choice to generalize to accurately simulate the
helicity of new peptides outside our data set. Simply taking
the accuracy of ein ¼ 4.1 in predicting these eight peptides
will tend to overestimate this accuracy, because this value has
been optimized to perform well on those peptides. Never-
theless, we can estimate the future (out-of-sample) predictive
accuracy from the current set of peptides using the statistical
method of cross-validation. We measure predictive accuracy
via the mean-squared error (MSE) between the predicted and
experimentally measure helicity values.
Cross-validation proceeds by removing one peptide (say
the ith one) from the dataset, and using the other seven to
estimate/optimize the parameter ein. Denote the resulting
parameter value by eˆ½i: We then use this value to simulate
the removed peptide and predict its helicity, calculating the
squared error between predicted and experimental values.
This process is then repeated to obtain similar predicted ac-
curacies for each of the peptides in turn, always using the
parameter value optimized over the other seven peptides, to
calculate the overall estimated predictive accuracy:
MSEcv ¼ 1
p
+
p
i¼1
ðhexpi  hˆ
eˆ½i
i Þ2:
This procedure has well-established properties as an unbi-
ased estimator of the out-of-sample predictive accuracy of
our parameter adaptation method (40). Because the vast
majority of our computational work is done upfront in
running the simulations of each peptide at each value of
ein, the expense of calculating the cross-validated prediction
accuracy is negligible.
Table 5 shows the MSE for each value of ein and the cross-
validated MSE; in this case the cross-validated MSE is equal
to the MSE for ein ¼ 4.1 since each eˆ½i was equal to 4.1.
Using the cross-validated MSE as an estimate of predictive
variance, the predictive standard deviation is 3.6% and a
standard interval prediction would contain simulated helicity
67.2%.
It is important to note the limitations of this current pre-
dictive accuracy estimate due to data size and composition. In
particular, the small dataset size leaves signiﬁcant variability
in the prediction accuracy estimate. In addition, cross-vali-
dation estimates the predictive accuracy for new data drawn
from the same population as the observed data. Thus, the
estimate of Table 5 is intended primarily as a demonstration
of the approach; it should be interpreted as an estimated
predictive accuracy for monomeric helical peptides, but may
FIGURE 7 Posterior distributions for the dielectric constant ein evaluated
at discrete values, obtained using Bayesian parameter updating described in
Bayesian Estimation of Force-Field Parameters under uniform prior. (Left)
Posterior over ein 2 f1, 2, 3, 4, 5g. (Right) An additional simulation was run
at ein ¼ 4.1 to help identify the mode of the posterior distribution.
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be less accurate for predominantly b-peptides, for example.
A signiﬁcantly enlarged and expanded dataset composition is
needed to address these issues more generally.
CONCLUSIONS
Macromolecular simulation is becoming a widely used tool
in structural and molecular biology. As usage grows and
computational resources continue to accelerate, the devel-
opment of true macromolecular computer experiments,
which can accurately and reproducibly calculate thermody-
namic or kinetic quantities that agree with experiment, is
within sight. For researchers developing or utilizing macro-
molecular simulation, it is an exciting time.
Here we have attempted to focus attention on use of sim-
ulation in this quantitative, prediction fashion. We have de-
scribed several statistical methods useful for addressing the
challenges in doing so: quantitative measures of simulation
convergence, construction of uncertainty intervals for simu-
lated quantities, Bayesian and shrinkage estimation for pa-
rameter adaptation, and the use of cross-validation to
evaluate predictive accuracy. We have also demonstrated the
use of this approach to evaluating and improving molecular
dynamics simulations of helical peptides, and explored the
sensitivity of such simulations to small changes in parameter
values. The tools described here are broadly applicable and
we hope they will be adopted by other researchers and will
help encourage further progress toward quantitative, predic-
tive simulations of macromolecular systems.
The results described here are only a ﬁrst step and may be
improved in a number of ways.We have used relatively small
amounts of data representing only equilibrium helicity in
FIGURE 8 Simulated helicity versus experimental helicity for the peptides in Table 1 evaluated at a range of values of the internal dielectric parameter ein.
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FIGURE 9 Helicity versus ein for each peptide in Table 1 at values of ein 2 f1, 2, 3, 4, 4.1, 5g. The experimentally measured helicity for each peptide is
plotted as a horizontal line.
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evaluating the predictive accuracy of our simulations, and
more sophisticated comparisons to detailed experimental
data will add signiﬁcantly more information to evaluate and
improve ensemble properties of simulations. Interesting re-
cent examples have been applied to short timescale peptide
kinetics (41,42) and comparison with nuclear magnetic res-
onance measurements (43,44). (Note that even when con-
sidering equilibrium helicity, Eq. 9 is crude, and may be more
accurate if replaced by a calculation of ellipticity (45) or an
entire CD spectrum for comparing with CD measurements;
however, calculation of CD spectra from conﬁgurations is
itself difﬁcult.)
In addition, as pointed out above in Cross-Validation, our
results may suffer from the use of helical peptides only, in our
data set. An expanded study including b-peptides is war-
ranted, as it is of signiﬁcant interest to determine parameters
appropriate for both a-helices and b-sheets. However, it is
important to note that our emphasis on quantitative evalua-
tion of equilibrium helical content (rather than, say, the min-
imum energy or most populated conformation) means that
accuracy suffers if the force ﬁeld either under- or overpredicts
a-helix, and so this evaluation is sensitive to underprediction
of b. Without direct measurements of b-content, however,
we cannot resolve errors in the b-to-coil proportions, so in-
clusion of quantitative equilibrium data on b-content of
b-hairpin peptides is of signiﬁcant interest. Unfortunately we
are currently limited by the lack of available experimental
FIGURE 10 Marginal posterior distributions of boundaries of the helical angle region (a) fmin and fmax, and (b) cmin and cmax.
TABLE 5 Mean-squared error (MSE) for each value of ein,
along with estimated out-of-sample prediction accuracy given
by MSE obtained from cross-validation
ein 1 2 3 4 4.1 5 CV
MSE 0.0405 0.0120 0.0025 0.0016 0.0013 0.0025 0.0013
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data in this area, due in no small part to difﬁculties in accu-
rately quantifying equilibrium b-content from CD and nu-
clear magnetic resonance data.
In the presence of more detailed experimental information,
the methods described in this article become even more
important in enabling reliable quantitative comparisons, and
for improving the predictive accuracy of force ﬁelds while
avoiding overﬁtting.
Similarly, the purpose of a molecular simulation is rarely
done simply to predict a single quantity such as helicity; and
when such predictions are desired, statistical models may
often be developed that are signiﬁcantly more accurate across
a wider range of input molecules (8). The advantage of a
simulation is the ability to examine many different ensemble
quantities calculated from a single simulation output. Nev-
ertheless, predictive evaluation of measured quantities will
help improve the underlying force ﬁelds and algorithms, thus
improving the accuracy of, relevance of, and conﬁdence in,
other quantities obtained from simulation output.
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